Menu

• Ask a Health Expert about ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE
• Post Your Side Effect related to ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE
• ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE and FDA Warnings
• ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE in Patients Wiki
• Report ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE in Drug Side Effect Survey

ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE side effect

What is ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Busulfan Side Effects Report #5663700-1
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Feb 22, 2008. Male patient, 80 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, amnesia, angiopathy, bk virus infection, blood culture positive, blood pressure increased, bone marrow transplant, . BUSULFAN dosage: 30.68 ML;QD;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE, VORICONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient died on 12/08/2007.

Campath Side Effects Report #5627818-1
CAMPATH problem was reported by a Physician from SPAIN on Feb 11, 2008. Male patient, 61 years of age, was diagnosed with acute graft versus host disease and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, fungal infection, . CAMPATH dosage: unknown. Patient was hospitalized. Patient died on 02/04/2008.

Alemtuzumab Side Effects Report #5630491-X
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, stem cell transplant, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, no therapeutic response, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, CORTICOSTEROIDS, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.

Cyclosporine Side Effects Report #5639007-5
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Feb 13, 2008. Female patient, child 12 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cholestasis, chronic graft versus host disease, gamma-glutamyltransferase increased, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, FLUDARABINE, BUSULFAN, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISONE. Patient died.


Cubicin Side Effects Report #5610337-6
Pharmacist from UNITED STATES reported CUBICIN problem on Oct 03, 2007. Female patient, 58 years of age, weighting 112.2 lb, was diagnosed with enterococcal bacteraemia and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, clostridium difficile colitis, condition aggravated, malnutrition, multi-organ failure, platelet count decreased, white blood cell count decreased, . CUBICIN dosage: 8 MG/KG; Q48H; IV. During the same period patient was treated with VANCOMYCIN, MEROPENEM, METRONIDAZOLE, SEPTRA DS, AZITHROMYCIN, FLUCONAZOLE, INSULIN, METHYLPREDNISOLONE. Patient recovered.

Prograf Side Effects Report #5535044-X
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 15, 2007. Male patient, 55 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, condition aggravated, encephalopathy, haemolytic anaemia, headache, influenza like illness, . PROGRAF dosage: 1 MG, UID/QD. Patient recovered.

Alemtuzumab Side Effects Report #5537517-2
Health Professional from UNITED STATES reported ALEMTUZUMAB problem on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache, . ALEMTUZUMAB dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.

Alemtuzumab Side Effects Report #5558177-0
ALEMTUZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache, . ALEMTUZUMAB dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.

Clofarabine Side Effects Report #5580933-3
Health Professional from UNITED STATES reported CLOFARABINE problem on Dec 10, 2007. Female patient, 14 years of age, weighting 57.00 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, acute lymphocytic leukaemia recurrent, alopecia, back pain, blood phosphorus decreased, caecitis, candidiasis, capillary leak syndrome, . CLOFARABINE dosage: 63 MG, QD, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, ALUMINUM HYDROXIDE, BISACODYL, DIPHENHYDRAMINE. Patient was hospitalized. Patient died on 11/18/2007.


Cytarabine Side Effects Report #5523546-1
CYTARABINE problem was reported by a Physician from GERMANY on Nov 06, 2007. Male patient, 24 years of age, was diagnosed with acute lymphocytic leukaemia, graft versus host disease and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, bk virus infection, complications of transplant surgery, cystitis haemorrhagic, hepatotoxicity, . CYTARABINE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, PURINE ANALOGUES. Patient recovered.

Ganciclovir Side Effects Report #5523568-0
Physician from UNITED STATES reported GANCICLOVIR problem on Nov 13, 2007. Male patient, 46 years of age, was diagnosed with cytomegalovirus infection and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, cytomegalovirus antigen positive, cytomegalovirus colitis, encephalitis cytomegalovirus, pancytopenia, renal failure chronic, sepsis, . GANCICLOVIR dosage: unknown. During the same period patient was treated with FOSCARNET, CIDOFOVIR, LEFLUNOMIDE. Patient was hospitalized. Patient died.

Fludarabine Side Effects Report #5524696-6
FLUDARABINE PHOSPHATE problem was reported by a Physician from SWITZERLAND on Nov 19, 2007. Male patient, 28 years of age, was diagnosed with bone marrow conditioning regimen and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, arthritis bacterial, bone marrow failure, bronchopulmonary aspergillosis, chronic graft versus host disease, cytomegalovirus infection, hypogammaglobulinaemia, pneumonitis, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE, PREDNISONE, RITUXIMAB, ETOPOSIDE, CARMUSTINE, CYTARABINE. Patient recovered.

Fludarabine Side Effects Report #5532973-8
Health Professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Nov 29, 2007. Male patient, weighting 209.4 lb, was diagnosed with chronic myelomonocytic leukaemia and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, bacteraemia, renal failure, respiratory disorder, urinary tract infection enterococcal, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with BUSULFAN, CAMPATH. Patient died on 11/23/2007.

Imatinib Side Effects Report #5474054-8
IMATINIB problem was reported by a Physician from FRANCE on Sept 25, 2007. Male patient, 39 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . IMATINIB dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.


Clofarabine Side Effects Report #5475351-2
Physician from UNITED STATES reported CLOFARABINE problem on Sept 25, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, bacteraemia, brain oedema, cardiac arrest, cystitis haemorrhagic, eye disorder, . CLOFARABINE dosage: 168.8 MG IV. During the same period patient was treated with BUSULFAN, FLUDARABINE PHOSPHATE, ACTIGALL, AMLODIPINE BESYLATE, BACTRIM, BUDESONIDE, CIPRO, CLARITIN. Patient was hospitalized. Patient died on 07/29/2007.

Imatinib Side Effects Report #5482093-6
IMATINIB problem was reported by a Physician from FRANCE on Oct 05, 2007. Male patient, 39 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . IMATINIB dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.

Fludarabine Side Effects Report #5483742-9
Consumer or non-health professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Oct 09, 2007. Male patient, weighting 150.1 lb, was diagnosed with myeloproliferative disorder and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, complications of transplant surgery, myeloproliferative disorder, neoplasm recurrence, stem cell transplant, . FLUDARABINE PHOSPHATE dosage: 70 MG DAILY FOR 5 DAYS IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, MYCOFUNGIN, ZOSYN, VANCOMYCIN, URSODIAL, DESONIDE CREAM, BUDESONIDE, METHOXALON. Patient died on 10/06/2007.

Thymoglobulin Side Effects Report #5489006-1
THYMOGLOBULIN problem was reported by a Physician from GERMANY on Sept 21, 2007. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with graft versus host disease and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, bone marrow failure, cardiac failure, condition aggravated, gastrointestinal haemorrhage, pneumonia, . THYMOGLOBULIN dosage: 80 MG QD IV. During the same period patient was treated with CANCIDAS, ROCEPHIN, DOXYCYCLINE, COTRIM, ACYCLOVIR, PENTAGLOBIN. Patient died on 09/19/2007.

Cgp Side Effects Report #5447200-X
Physician from FRANCE reported CGP problem on Sept 05, 2007. Male patient, 49 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . CGP dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.


Prograf Side Effects Report #5408510-5
PROGRAF problem was reported by a Physician from UNITED STATES on July 16, 2007. Female patient, 53 years of age, was diagnosed with graft versus host disease and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, cytomegalovirus infection, diarrhoea, pneumonia cytomegaloviral, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE METHOTREXATE. Patient died.

Interferon Side Effects Report #5411159-1
Physician from JAPAN reported INTERFERON GAMMA problem on July 11, 2007. Male patient, 56 years of age, was diagnosed with metastatic neoplasm and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, cancer in remission, clear cell carcinoma of the kidney, hyperkalaemia, malignant neoplasm progression, transplant rejection, . INTERFERON GAMMA dosage: unknown. Patient recovered.

Prograf Side Effects Report #5421298-7
PROGRAF problem was reported by a Physician from UNITED STATES on July 23, 2007. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, disease progression, fungal infection, lung neoplasm, mantle cell lymphoma, skin lesion, systemic mycosis, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, COTRIM, ACYCLOVIR, VORICONAZOLE. Patient was hospitalized. Patient died.

Aranesp Side Effects Report #5377446-0
Physician from UNITED STATES reported ARANESP problem on June 22, 2007. Female patient, 55 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, anaemia, surgical procedure repeated, transplant, transplant failure, viral infection, . ARANESP dosage: unknown. During the same period patient was treated with TACROLIMUS, IMMUNOSUPPRESSANTS, ANTIBIOTIC NOS. Patient was hospitalized. Patient died.

Sandimmune Side Effects Report #5379698-X
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.

Sandimmune Side Effects Report #5379891-6
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.

Cyclosporine Side Effects Report #5389849-9
CYCLOSPORINE problem was reported by a Health Professional from AUSTRALIA on July 09, 2007. Male patient, 39 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, blood lactate dehydrogenase increased, hypoxia, ileus, lethargy, life support, lung infiltration, mucosal inflammation, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, ETOPOSIDE, IRRADIATION, NEUPOGEN. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390762-1
Physician from CANADA reported ALDURAZYME problem on July 15, 2005. Female patient, weighting 24.00 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, bronchopulmonary aspergillosis, dystrophic calcification, fungal infection, obliterative bronchiolitis, pancreatitis, pneumonia, . ALDURAZYME dosage: unknown. During the same period patient was treated with PREDNISONE. Patient died on 11/21/2004.

Aranesp Side Effects Report #5377446-0
ARANESP problem was reported by a Physician from UNITED STATES on June 22, 2007. Female patient, 55 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, anaemia, surgical procedure repeated, transplant, transplant failure, viral infection, . ARANESP dosage: unknown. During the same period patient was treated with TACROLIMUS, IMMUNOSUPPRESSANTS, ANTIBIOTIC NOS. Patient was hospitalized. Patient died.

Sandimmune Side Effects Report #5379698-X
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.

Sandimmune Side Effects Report #5379891-6
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.

Cyclosporine Side Effects Report #5389849-9
Health Professional from AUSTRALIA reported CYCLOSPORINE problem on July 09, 2007. Male patient, 39 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, blood lactate dehydrogenase increased, hypoxia, ileus, lethargy, life support, lung infiltration, mucosal inflammation, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, ETOPOSIDE, IRRADIATION, NEUPOGEN. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390762-1
ALDURAZYME problem was reported by a Physician from CANADA on July 15, 2005. Female patient, weighting 24.00 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, bronchopulmonary aspergillosis, dystrophic calcification, fungal infection, obliterative bronchiolitis, pancreatitis, pneumonia, . ALDURAZYME dosage: unknown. During the same period patient was treated with PREDNISONE. Patient died on 11/21/2004.

Busulfex Side Effects Report #5767263-1
Consumer or non-health professional from FRANCE reported BUSULFEX problem on May 27, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died.

Busulfex Side Effects Report #5767606-9
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on May 27, 2008. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, encephalitis viral, . BUSULFEX dosage: 4 MG/KG. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.

Busulfex Side Effects Report #5767661-6
Consumer or non-health professional from ISRAEL reported BUSULFEX problem on May 27, 2008. Male patient, 37 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cerebral haemorrhage, no therapeutic response, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient was hospitalized. Patient died.

Busulfex Side Effects Report #5767667-7
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on May 27, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute respiratory distress syndrome, aspergillosis, encephalitis, engraftment syndrome, lymphoma, thrombotic thrombocytopenic purpura, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient was hospitalized. Patient died.

Campath Side Effects Report #5785948-8
Physician from JAPAN reported CAMPATH problem on June 18, 2008. Male patient, 47 years of age, weighting 141.1 lb, was diagnosed with aplastic anaemia, prophylaxis against graft versus host disease, tuberculous pleurisy and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, anorexia, cytomegalovirus antigen positive, diarrhoea, weight decreased, . CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, CYCLOSPORINE, NEORAL, URSO, ADEROXAL, ISCOTIN, PYRAMIDE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5737859-1
CAMPATH problem was reported by a Physician from JAPAN on May 07, 2008. Male patient, 47 years of age, weighting 141.1 lb, was diagnosed with aplastic anaemia, prophylaxis against graft versus host disease, tuberculous pleurisy and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, anorexia, cytomegalovirus antigen positive, diarrhoea, weight decreased, . CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, CYCLOSPORINE, NEORAL, URSO, ADEROXAL, ISCOTIN, PYRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5738390-X
Physician from UNITED STATES reported VELCADE problem on May 01, 2008. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, . VELCADE dosage: 2.7 MG, INTRAVENOUS. During the same period patient was treated with IDARUBICIN, CYTARABINE, MAGNESIUM SULPHATE, POTASSIUM CHLORIDE, MEPRON, NYSTATIN, NEXIUM, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5697439-3
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2008. Male patient, child 12 years of age, was diagnosed with acute graft versus host disease in skin, prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, blast cells present, bronchopulmonary aspergillosis, computerised tomogram abnormal, graft versus host disease in lung, obliterative bronchiolitis, oxygen saturation decreased, pancytopenia, pneumomediastinum, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, CYCLOPHOSPHAMIDE. Patient died.

Cyclosporine Side Effects Report #5348881-1
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 01, 2007. Male patient, child 10 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN. Patient died.

Tazocilline Side Effects Report #5353488-6
TAZOCILLINE problem was reported by a Health Professional from FRANCE on June 07, 2007. Female patient, 16 years of age, was diagnosed with acute myeloid leukaemia and was treated with TAZOCILLINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, diarrhoea, megacolon, . TAZOCILLINE dosage: unknown. During the same period patient was treated with GENTAMICIN SULPHATE, FLUDARA, ARACYTINE. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5368182-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 13, 2007. Male patient, 31 years of age, was diagnosed with graft versus host disease, lung infiltration and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, blood amylase increased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, cough, cryptogenic organising pneumonia, cytomegalovirus antigen positive, . CYCLOSPORINE dosage: 60 MG/DAY. During the same period patient was treated with IRRADIATION, CYCLOPHOSPHAMIDE, CYTARABINE, NEUPOGEN, METHOTREXATE, PREDNISOLONE. Patient recovered.

Posaconazole Side Effects Report #5323102-4
POSACONAZOLE problem was reported by a Physician from GERMANY on Apr 23, 2007. Male patient, 61 years of age, weighting 174.2 lb, was diagnosed with fungal infection, prophylaxis against graft versus host disease, antiviral prophylaxis and was treated with POSACONAZOLE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, cholelithiasis, cholestasis, constipation, convulsion, cystitis, cytomegalovirus infection, dehydration, . POSACONAZOLE dosage: 200 MG; QID; PO. During the same period patient was treated with PROGRAF, ACYCLOVIR, SANDIMMUNE, DECORTIN, CELLCEPT, GANCICLOVIR, BELOC ZOC COMP. Patient was hospitalized. Patient died on 05/21/2006.

Cyclosporine Side Effects Report #5338115-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on May 23, 2007. Male patient, child 10 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, haemorrhage intracranial, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN. Patient died.

Radiation Side Effects Report #5284255-X
RADIATION problem was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2007. Male patient, 46 years of age, weighting 127.9 lb, was diagnosed with bone marrow transplant and was treated with RADIATION. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, colitis, diarrhoea, haematochezia, opportunistic infection, pneumocystis jiroveci pneumonia, pyrexia, rash, . RADIATION dosage: unknown. During the same period patient was treated with METHOTREXATE, SANDIMMUNE, NEORAL. Patient died on 07/24/2003.

Tazocilline Side Effects Report #5304214-8
Health Professional from FRANCE reported TAZOCILLINE problem on Apr 18, 2007. Female patient, 16 years of age, was diagnosed with acute myeloid leukaemia and was treated with TAZOCILLINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, diarrhoea, megacolon, . TAZOCILLINE dosage: unknown. During the same period patient was treated with GENTAMICIN SULPHATE, FLUDARA, ARACYTINE. Patient was hospitalized. Patient recovered.

Radiation Side Effects Report #5255191-X
RADIATION problem was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2007. Male patient, 46 years of age, weighting 127.9 lb, was diagnosed with bone marrow transplant and was treated with RADIATION. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, colitis, diarrhoea, haematochezia, opportunistic infection, pneumocystis jiroveci pneumonia, pyrexia, rash, . RADIATION dosage: unknown. During the same period patient was treated with METHOTREXATE, SANDIMMUNE, NEORAL. Patient died on 07/24/2003.

Prograf Side Effects Report #5259838-3
Physician from UNITED STATES reported PROGRAF problem on Feb 22, 2007. Male patient, 51 years of age, was diagnosed with prophylaxis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, bk virus infection, bronchopulmonary aspergillosis, cystitis haemorrhagic, grand mal convulsion, lymphopenia, positron emission tomogram abnormal, progressive multifocal leukoencephalopathy, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient died.

Prograf Side Effects Report #5259842-5
PROGRAF problem was reported by a Physician from UNITED STATES on Feb 22, 2007. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, bulbar palsy, dysarthria, jc virus infection, lymphopenia, no therapeutic response, progressive multifocal leukoencephalopathy, quadriparesis, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient died.

Cyclosporine Side Effects Report #5262913-0
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Feb 27, 2007. Male patient, 48 years of age, was diagnosed with stem cell transplant, acute graft versus host disease in intestine and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, anorexia, aplasia pure red cell, blood copper decreased, blood magnesium decreased, blood zinc decreased, bone marrow failure, chronic graft versus host disease, diarrhoea, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with BUSULFAN, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL, GANCICLOVIR. Patient recovered.